Search results
EMA Panel Endorses Novavax's (NVAX) COVID Jab for Full Approval
Zacks via Yahoo Finance· 11 months agoNovavax's (NVAX) protein-based COVID-19 vaccine gets recommendation for full marketing authorization...
Novavax's (NVAX) COVID-19 Jab Gets Approval in Switzerland
Zacks via Yahoo Finance· 2 years agoNovavax (NVAX) receives expanded temporary authorization for Nuvaxovid, its COVID-19 vaccine, in...
Novavax Stock Is Too Sickly To Buy
InvestorPlace via Yahoo Finance· 2 years agoNovavax’s Covid-19 vaccine still isn’t approved for use in the U.S. With the pandemic in full retreat and the majority of people now fully vaccinated,...
Novavax Covid vaccine becomes fourth to receive FDA approval
The Independent via Yahoo News· 2 years agoThe Food and Drug Administration authorised the use of Novavax Covid-19 vaccine for adults on...
Novavax' Sees Conditional Approval Of COVID-19 Vaccine Booster In Australia As US FDA Delays Its...
Benzinga via Yahoo Finance· 2 years agoThe Australian regulatory authority has conditionally approved Novavax Inc's (NASDAQ: NVAX)...
Novavax's updated COVID-19 vaccine gets FDA approval
United Press International via Yahoo News· 7 months agoFederal regulators on Tuesday gave the go-ahead to an updated Novavax COVID-19 vaccine, giving Americans a more traditional alternative to two recently...
Novavax CEO eyes next batch of COVID-19 vaccines after CDC approval
Yahoo Finance· 2 years agoNovavax passed the finish line to gain authorization for its COVID-19 vaccine, and its first...
Novavax Covid Vaccine Could Soon Win EUA Approval — And So What?
TipRanks via Yahoo Finance· 2 years agoAt long last, Novavax (NVAX) may be close to getting its EUA. As the company announced late Tuesday,...
Novavax, Inc. (NASDAQ:NVAX) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 months agoNovavax, Inc. (NASDAQ:NVAX) Q4 2023 Earnings Call Transcript February 28, 2024 Novavax, Inc. misses...
Why Novavax Stock Tumbled 28% in the First Half of 2023
Motley Fool· 9 months agoWhat happened Shares of Novavax (NASDAQ: NVAX) lost 28% of their value in the first six months of...